Source: Annual Congress 2005 - Asbestos, coal mining and jeans blasting: old and new causes of occupational respiratory disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Tsyura, I. Malysheva, G. Orlova, A. Bazhanov (St. Petersburg, Russian Federation). Assessment of anti-inflammatory cytokines in professional lung diseases. Eur Respir J 2005; 26: Suppl. 49, 983

Member's Comments

No comment yet.

Related content which might interest you: The role anti-inflammatory cytokines in pathogenesis professional occupetional pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 122s Year: 2003 Local and systemic imbalance of pro- and antiinflammatory cytokines in COPD Source: Annual Congress 2009 - Airway inflammation and host defence Year: 2009 Role of anti-inflammatory treatments in complex chronic comorbidities Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 The levels of proinflammatory cytokines in patients with dust-induced lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 536s Year: 2001 Pro-inflammatory cytokines in pathogenesis professional occupetional pulmonary disease Source: Eur Respir J 2004; 24: Suppl. 48, 148s Year: 2004 Targeting TNF-alpha in inflammatory lung diseases Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes Year: 2005 Proinflammatory cytokines production in patients with purulent destructive lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 105s Year: 2001 Effects of dexamethasone and anti-inflammatory drugs on inflammatory cytokines from bronchial epithelial cells of COPD patients Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Dynamic of proinflammatory cytokines system and nonspecific markers of inflammation in patients with COPD before and after treatment with broncholitics Source: Eur Respir J 2006; 28: Suppl. 50, 38s Year: 2006 Comparative characteristics of cytokines in BAL fluid in occupational lung diseases and COPD Source: Eur Respir J 2006; 28: Suppl. 50, 190s Year: 2006 The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Presentation by an expert: IL17 and the development of inflammatory airway diseases Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease Year: 2013 The role of proinflammatory cytokines in severe COPD patients before and after roflumilast treatment Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016 Systemic cytokine signaling via IL-17 and its relation to clinical characteristics in children with asthma Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers Year: 2015 Monitoring anti-inflammatory treatments in IPF and related disorders Source: Annual Congress 2004 - Pathobiological methodologies in monitoring immunomodulatory treatments Year: 2004 An evaluation of circulating cytokines milieu in patients with asthma Source: Eur Respir J 2002; 20: Suppl. 38, 311s Year: 2002 An update on anti-inflammatory endogenous mediators Source: Annual Congress 2005 - Mechanisms of resolution of inflammation Year: 2005 Aerobic exercise reduces pulmonary inflammation in diet-induced obesity in a HDM model of asthma through adipokines, IL-10, IL-17 and IL-23 signaling Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 Rosuvastatin influence on inflammatory and anti-inflammatory cytokines in blood in patients with chronic obstructive pulmonary disease Source: International Congress 2017 – COPD management Year: 2017